Top

Gepubliceerd in:

24-01-2023 | ORIGINAL PAPER

Intensive Mindfulness Meditation Reduces Frequency and Burden of Migraine: An Unblinded Single-Arm Trial

Auteurs: Madhav Goyal, Jennifer A. Haythornthwaite, Sharat Jain, Barbara Lee Peterlin, Megha Mehrotra, David Levine, Jason D. Rosenberg, Mary Minges, David A. Seminowicz, Daniel E. Ford

Gepubliceerd in: Mindfulness | Uitgave 2/2023

Abstract

Objectives

Preventing migraine headaches and improving the quality of life for patients with migraine remains a challenge. We hypothesized intensive meditation training would reduce the disease burden of migraine.

Method

An unblinded trial was analyzed as a single cohort exposed to a silent 10-day Vipassana meditation retreat that included 100 hr of sitting meditation. Participants with chronic or episodic migraine were enrolled and followed for 1 year. The primary outcome was a change in mean monthly migraine days at 12 months from baseline. Secondary outcomes included headache frequency and intensity, acute medication use, work days missed, home meditation, sleep quality, general health, quality of life, migraine impact, positive and negative affect, perceived stress, mindfulness, and pain catastrophizing.

Results

Three hundred people were screened and 58 (19%) agreed to participate and enrolled in the intensive meditation training. Forty-six participants with chronic migraine (≥ 15 headaches/month of which ≥ 8 were migraines) and 12 with episodic migraine (< 15 and ≥ 4 migraines/month) attended and 45 (78%) completed the retreat. At 12 months, the average migraine frequency was reduced by 2.7 days (from 16.6 at baseline) per 28 days (95%CI − 4.3, − 1.3) and headaches by 3.4 (20.1 at baseline) per 28 days (− 4.9, − 1.9). Fifty percent responder rate was 29% for migraine. Acute medication use dropped by an average of 2.2 days (− 3.9, − 0.5) per 28 days, and participants reported 2.3 fewer days (− 4.0, − 0.5) on which they reduced their activity due to migraines. The most striking and promising effects were in several secondary outcomes, including migraine-specific quality of life, pain catastrophizing, and perceived stress. The significant improvements observed immediately following the intervention were sustained at 12 months follow-up.

Conclusions

Training in Vipassana meditation via a 10-day retreat may reduce the frequency and burden of migraine.

Preregistration

ClinicalTrials.gov: NCT00663585.

vorige artikel The Protective Effect of Trait Mindfulness on the Associations Between Negative Perfectionism and Suicidal Ideation Among Chinese Adolescents: A Longitudinal Moderated Mediation Model

volgende artikel Dysfunctional Attitudes Toward Motherhood and Depressive Symptoms in Portuguese Pregnant Women During COVID-19 Pandemic: the Mediating Roles of Self-Compassion and Mindful Self-Care

Alleen toegankelijk voor geautoriseerde gebruikers

Al-Hussaini, A., Dorvlo, A. S., Antony, S. X., Chavan, D., Dave, J., Purecha, V., Al-Rahbi, S., & Al-Adawi, S. (2001). Vipassana meditation: A naturalistic, preliminary observation in Muscat. Journal for Scientific Research: Medical Sciences, 3(2), 87–92.PubMedPubMedCentral

Bagley, C. L., Rendas-Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., & Kosinski, M. (2012). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache, 52(3), 409–421. https://doi.org/10.1111/j.1526-4610.2011.01997.xCrossRefPubMed

Bond, D. S., Buse, D. C., Lipton, R. B., Thomas, J. G., Rathier, L., Roth, J., Pavlovic, J. M., Evans, E. W., & Wing, R. R. (2015). Clinical pain catastrophizing in women with migraine and obesity. Headache, 55(7), 923–933. https://doi.org/10.1111/head.12597CrossRefPubMedPubMedCentral

Bowen, S., Witkiewitz, K., Dillworth, T. M., Chawla, N., Simpson, T. L., Ostafin, B. D., Larimer, M. E., Blume, A. W., Parks, G. A., & Marlatt, G. A. (2006). Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors, 20(3), 343–347. https://doi.org/10.1037/0893-164X.20.3.343CrossRefPubMed

Brandes, J. L., Saper, J. R., Diamond, M., Couch, J. R., Lewis, D. W., Schmitt, J., Neto, W., Schwabe, S., Jacobs, D., MS Group. (2004). Topiramate for migraine prevention: A randomized controlled trial. JAMA, 291(8), 965–973. https://doi.org/10.1001/jama.291.8.965CrossRefPubMed

Buenaver, L. F., Edwards, R. R., & Haythornthwaite, J. A. (2007). Pain-related catastrophizing and perceived social responses: Inter-relationships in the context of chronic pain. Pain, 127(3), 234–242. https://doi.org/10.1016/j.pain.2006.08.018CrossRefPubMed

Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385–396. https://doi.org/10.2307/2136404

Cottrell, C. K., Drew, J. B., Waller, S. E., Holroyd, K. A., Brose, J. A., & O’Donnell, F. J. (2002). Perceptions and needs of patients with migraine: A focus group study. Journal of Family Practice, 51(2), 142–147. https://doi.org/10.1046/j.1526-4610.2003.03085_17.x

Detke, H. C., Goadsby, P. J., Wang, S., Friedman, D. I., Selzler, K. J., & Aurora, S. K. (2018). Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. Neurology, 91(24), e2211–e2221. https://doi.org/10.1212/WNL.0000000000006640CrossRefPubMedPubMedCentral

Diener, H. C., Tfelt-Hansen, P., Dahlof, C., Lainez, M. J., Sandrini, G., Wang, S. J., Neto, W., Vijapurkar, U., Doyle, A., Jacobs, D., MS Group. (2004). Topiramate in migraine prophylaxis–Results from a placebo-controlled trial with propranolol as an active control. Journal of Neurology, 251(8), 943–950. https://doi.org/10.1007/s00415-004-0464-6CrossRefPubMed

Dodick, D. W., Silberstein, S. D., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2018). Effect of fremanezumab compared with placebo for prevention of episodic migraine: A randomized clinical trial. JAMA, 319(19), 1999–2008. https://doi.org/10.1001/jama.2018.4853CrossRefPubMed

Failde, I., Ramos, I., & Fernandez-Palacin, F. (2000). Comparison between the GHQ-28 and SF-36 (MH 1–5) for the assessment of the mental health in patients with ischaemic heart disease. European Journal of Epidemiology, 16(4), 311–316. https://doi.org/10.1023/a:1007688525023CrossRefPubMed

Frawley, J., Sibbritt, D., Broom, A., Gallois, C., Steel, A., & Adams, J. (2016). Womenʹs attitudes towards the use of complementary and alternative medicine products during pregnancy. Journal of Obstetrics and Gynaecology, 36(4), 462–467. https://doi.org/10.3109/01443615.2015.1072804CrossRefPubMed

Goldberg, D. P., & Hillier, V. F. (1979). A scaled version of the General Health Questionnaire. Psychological Medicine, 9(1), 139–145. https://doi.org/10.1017/s0033291700021644CrossRefPubMed

Goslin, R. E., Gray, R. N., McCrory, D. C., Penzien, D., Rains, J., & Hasselblad, V. (1999). Behavioral and physical treatments for migraine headache (National Technical Information Service (NTIS) Accession No. PB99–127946). Department of Health and Human Services. http://www.ncbi.nlm.nih.gov/pubmed/20734517. Accessed 28 June 2022

Goyal, M., Singh, S., Sibinga, E. M., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., Ranasinghe, P. D., Linn, S., Saha, S., Bass, E. B., & Haythornthwaite, J. A. (2014). Meditation programs for psychological stress and well-being: A systematic review and meta-analysis. JAMA Internal Medicine, 174(3), 357–368. https://doi.org/10.1001/jamainternmed.2013.13018CrossRefPubMedPubMedCentral

Grazzi, L., Sansone, E., Raggi, A., D’Amico, D., De Giorgio, A., Leonardi, M., De Torres, L., Salgado-Garcia, F., & Andrasik, F. (2017). Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: An effectiveness trial with a one-year follow-up. Journal of Headache and Pain, 18(1), 15. https://doi.org/10.1186/s10194-017-0728-zCrossRefPubMedPubMedCentral

Harris, P., Loveman, E., Clegg, A., Easton, S., & Berry, N. (2015). Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. British Journal of Pain, 9(4), 213–224. https://doi.org/10.1177/2049463715578291CrossRefPubMedPubMedCentral

Hart, W. (2005). The art of living: Vipassana meditation as taught by S.N. Goenka. Vipassana Research Institute.

Holroyd, K. A., Drew, J. B., Cottrell, C. K., Romanek, K. M., & Heh, V. (2007). Impaired functioning and quality of life in severe migraine: The role of catastrophizing and associated symptoms. Cephalalgia, 27(10), 1156–1165. https://doi.org/10.1111/j.1468-2982.2007.01420.xCrossRefPubMedPubMedCentral

International Headache Society. (2020). The international classification of headache disorders 3rd edition. Retrieved 8/5/20 from https://ichd-3.org/1-migraine/1-1-migraine-without-aura/

Jackson, J. L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., Sehgal, N., & Kuester, J. (2015). A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS ONE, 10(7), e0130733. https://doi.org/10.1371/journal.pone.0130733

Karam, F., Berard, A., Sheehy, O., Huneau, M. C., Briggs, G., Chambers, C., Einarson, A., Johnson, D., Kao, K., Koren, G., Martin, B., Polifka, J. E., Riordan, S. H., Roth, M., Lavigne, S. V., Wolfe, L., & Committee, O. R. (2012). Reliability and validity of the 4-item perceived stress scale among pregnant women: Results from the OTIS antidepressants study. Research in Nursing and Health, 35(4), 363–375. https://doi.org/10.1002/nur.21482CrossRefPubMed

Khoury, B., Knauper, B., Schlosser, M., Carriere, K., & Chiesa, A. (2017). Effectiveness of traditional meditation retreats: A systematic review and meta-analysis. Journal of Psychosomatic Research, 92, 16–25. https://doi.org/10.1016/j.jpsychores.2016.11.006CrossRefPubMed

Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68(5), 343–349. https://doi.org/10.1212/01.wnl.0000252808.97649.21CrossRefPubMed

Lipton, R. B., Buse, D. C., Hall, C. B., Tennen, H., Defreitas, T. A., Borkowski, T. M., Grosberg, B. M., & Haut, S. R. (2014). Reduction in perceived stress as a migraine trigger: Testing the “let-down headache” hypothesis. Neurology, 82(16), 1395–1401. https://doi.org/10.1212/WNL.0000000000000332CrossRefPubMedPubMedCentral

Loder, E., & Rizzoli, P. (2018). Pharmacologic prevention of migraine: A narrative review of the state of the art in 2018. Headache, 58(Suppl 3), 218–229. https://doi.org/10.1111/head.13375CrossRefPubMed

Manack, A. N., Buse, D. C., & Lipton, R. B. (2011). Chronic migraine: Epidemiology and disease burden. Current Pain and Headache Reports, 15(1), 70–78. https://doi.org/10.1007/s11916-010-0157-zCrossRefPubMed

Martin, P. R. (2016). Stress and primary headache: Review of the research and clinical management. Current Pain and Headache Reports, 20(7), 45. https://doi.org/10.1007/s11916-016-0576-6CrossRefPubMed

Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000). Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache, 40(3), 204–215. https://doi.org/10.1046/j.1526-4610.2000.00030.x

Maruthai, N., Nagendra, R. P., Sasidharan, A., Srikumar, S., Datta, K., Uchida, S., & Kutty, B. M. (2016). Senior Vipassana meditation practitioners exhibit distinct REM sleep organization from that of novice meditators and healthy controls. International Review of Psychiatry, 28(3), 279–287. https://doi.org/10.3109/09540261.2016.1159949CrossRefPubMed

Mitchell, A. M., Crane, P. A., & Kim, Y. (2008). Perceived stress in survivors of suicide: Psychometric properties of the Perceived Stress Scale. Research in Nursing and Health, 31(6), 576–585. https://doi.org/10.1002/nur.20284CrossRefPubMed

Montero-Marin, J., Puebla-Guedea, M., Herrera-Mercadal, P., Cebolla, A., Soler, J., Demarzo, M., Vazquez, C., Rodriguez-Bornaetxea, F., & Garcia-Campayo, J. (2016). Psychological effects of a 1-month meditation retreat on experienced meditators: The role of non-attachment. Frontiers in Psychology, 7, 1935. https://doi.org/10.3389/fpsyg.2016.01935CrossRefPubMedPubMedCentral

National Center for Complementary and Integrative Health. (2019). Complementary, alternative, or integrative health: What’s in a name? U.S. Department of Health and Human Services. Retrieved October 31, 2019 from https://nccih.nih.gov/health/integrative-health#hed4

Osman, A., Barrios, F. X., Gutierrez, P. M., Kopper, B. A., Merrifield, T., & Grittmann, L. (2000). The Pain Catastrophizing Scale: Further psychometric evaluation with adult samples. Journal of Behavioral Medicine, 23(4), 351–365. https://doi.org/10.1023/a:1005548801037CrossRefPubMed

Penzien, D. B., Andrasik, F., Freidenberg, B. M., Houle, T. T., Lake, A. E., 3rd., Lipchik, G. L., Holroyd, K. A., Lipton, R. B., McCrory, D. C., Nash, J. M., Nicholson, R. A., Powers, S. W., Rains, J. C., & Wittrock, D. A. (2005). Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache, 45(Suppl 2), S110–S132. https://doi.org/10.1111/j.1526-4610.2005.4502004.x

Perelman, A., Miller, S. L., Clements, C. B., Rodriguez, A., Allen, K., & Cavanaugh, R. (2012). Meditation in a deep south prison: A longitudinal study of the effects of Vipassana. Journal of Offender Rehabilitation, 51, 176–198. https://doi.org/10.1080/10509674.2011.632814CrossRef

Podsakoff, P. M., MacKenzie, S. B., & Podsakoff, N. P. (2012). Sources of method bias in social science research and recommendations on how to control it. Annual Review of Psychology, 63, 539–569. https://doi.org/10.1146/annurev-psych-120710-100452CrossRefPubMed

Probyn, K., Bowers, H., Mistry, D., Caldwell, F., Underwood, M., Patel, S., Sandhu, H. K., Matharu, M., Pincus, T., C team. (2017). Non-pharmacological self-management for people living with migraine or tension-type headache: A systematic review including analysis of intervention components. BMJ Open, 7(8), e016670. https://doi.org/10.1136/bmjopen-2017-016670CrossRefPubMedPubMedCentral

Reuter, U., Goadsby, P. J., Lanteri-Minet, M., Wen, S., Hours-Zesiger, P., Ferrari, M. D., & Klatt, J. (2018). Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: A randomised, double-blind, placebo-controlled, phase 3b study. Lancet, 392(10161), 2280–2287. https://doi.org/10.1016/S0140-6736(18)32534-0CrossRefPubMed

Robinson, R. G., & Price, T. R. (1982). Post-stroke depressive disorders: A follow-up study of 103 patients. Stroke, 13(5), 635–641. https://doi.org/10.1161/01.str.13.5.635CrossRefPubMed

Ronel, N., Frid, N., & Timor, U. (2013). The practice of positive criminology: A Vipassana course in prison. International Journal of Offender Therapy and Comparative Criminology, 57(2), 133–153.CrossRefPubMed

Schoonman, G. G., Evers, D. J., Ballieux, B. E., de Geus, E. J., de Kloet, E. R., Terwindt, G. M., van Dijk, J. G., & Ferrari, M. D. (2007). Is stress a trigger factor for migraine? Psychoneuroendocrinology, 32(5), 532–538. https://doi.org/10.1016/j.psyneuen.2007.03.006CrossRefPubMed

Schramm, S. H., Moebus, S., Lehmann, N., Galli, U., Obermann, M., Bock, E., Yoon, M. S., Diener, H. C., & Katsarava, Z. (2015). The association between stress and headache: A longitudinal population-based study. Cephalalgia, 35(10), 853–863. https://doi.org/10.1177/0333102414563087CrossRefPubMed

Seminowicz, D. A., Burrowes, S. A. B., Kearson, A., Zhang, J., Krimmel, S. R., Samawi, L., Furman, A. J., Keaser, M. L., Gould, N. F., Magyari, T., White, L., Goloubeva, O., Goyal, M., Peterlin, B. L., & Haythornthwaite, J. A. (2020). Enhanced mindfulness-based stress reduction in episodic migraine: A randomized clinical trial with magnetic resonance imaging outcomes. Pain, 161(8), 1837–1846. https://doi.org/10.1097/j.pain.0000000000001860CrossRefPubMedPubMedCentral

Seng, E. K., Singer, A. B., Metts, C., Grinberg, A. S., Patel, Z. S., Marzouk, M., Rosenberg, L., Day, M., Minen, M. T., Lipton, R. B., & Buse, D. C. (2019). Does mindfulness-based cognitive therapy for migraine reduce migraine-related disability in people with episodic and chronic migraine? A phase 2b pilot randomized clinical trial. Headache, 59(9), 1448–1467. https://doi.org/10.1111/head.13657CrossRefPubMedPubMedCentral

Shamliyan, T. A., Choi, J. Y., Ramakrishnan, R., Miller, J. B., Wang, S. Y., Taylor, F. R., & Kane, R. L. (2013). Preventive pharmacologic treatments for episodic migraine in adults. Journal of General Internal Medicine, 28(9), 1225–1237. https://doi.org/10.1007/s11606-013-2433-1CrossRefPubMedPubMedCentral

Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., Brandes, J. L., Bigal, M., Saper, J., Ascher, S., Jordan, D. M., Greenberg, S. J., Hulihan, J., Topiramate Chronic Migraine Study Group. (2007). Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache, 47(2), 170–180. https://doi.org/10.1111/j.1526-4610.2006.00684.xCrossRefPubMed

Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2017). Fremanezumab for the preventive treatment of chronic migraine. New England Journal of Medicine, 377(22), 2113–2122. https://doi.org/10.1056/NEJMoa1709038CrossRefPubMed

Simshauser, K., Luking, M., Kaube, H., Schultz, C., & Schmidt, S. (2020). Is Mindfulness-Based Stress Reduction a promising and feasible intervention for patients suffering from migraine? A randomized controlled pilot trial. Complementary Medicine Research, 27(1), 19–30. https://doi.org/10.1159/000501425CrossRefPubMed

Speck, R. M., Yu, R., Ford, J. H., Ayer, D. W., Bhandari, R., & Wyrwich, K. W. (2021). Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine. Headache, 61(3), 511–526. https://doi.org/10.1111/head.14031CrossRefPubMedPubMedCentral

Stauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018). Evaluation of galcanezumab for the prevention of episodic migraine: The EVOLVE-1 randomized clinical trial. JAMA Neurology, 75(9), 1080–1088. https://doi.org/10.1001/jamaneurol.2018.1212CrossRefPubMedPubMedCentral

Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001). Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology, 56(6 Suppl 1), S20–S28. https://doi.org/10.1212/wnl.56.suppl_1.s20

Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The pain catastrophizing scale: Development and validation. Psychological Assessment, 7(4), 524–532. https://doi.org/10.1037/1040-3590.7.4.524

Sullivan, M. J., Thorn, B., Haythornthwaite, J. A., Keefe, F., Martin, M., Bradley, L. A., & Lefebvre, J. C. (2001). Theoretical perspectives on the relation between catastrophizing and pain. Clinical Journal of Pain, 17(1), 52–64. https://doi.org/10.1097/00002508-200103000-00008

Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Dolezil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017). Safety and efficacy of erenumab for preventive treatment of chronic migraine: A randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurology, 16(6), 425–434. https://doi.org/10.1016/S1474-4422(17)30083-2CrossRefPubMed

Vipassana Introduction to the Technique. (2022). https://www.dhamma.org/en-US/about/code. Accessed 28 June 2022

Vipassana website. (2022). www.dhamma.org

Walach, H., Buchheld, N., Buttenmuller, V., Kleinknecht, N., & Schmidt, S. (2006). Measuring mindfulness–the freiburg mindfulness inventory (FMI). Personality and Individual Differences, 40(8), 1543–1555. https://doi.org/10.1016/j.paid.2005.11.025

Warttig, S. L., Forshaw, M. J., South, J., & White, A. K. (2013). New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4). Journal of Health Psychology, 18(12), 1617–1628. https://doi.org/10.1177/1359105313508346CrossRefPubMed

Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54(6), 1063–1070. https://doi.org/10.1037//0022-3514.54.6.1063CrossRefPubMed

Wells, R. E., Seng, E. K., Edwards, R. R., Victorson, D. E., Pierce, C. R., Rosenberg, L., Napadow, V., & Schuman-Olivier, Z. (2020). Mindfulness in migraine: A narrative review. Expert Review of Neurotherapeutics, 20(3), 207–225. https://doi.org/10.1080/14737175.2020.1715212CrossRefPubMedPubMedCentral

Wells, R. E., O’Connell, N., Pierce, C. R., Estave, P., Penzien, D. B., Loder, E., Zeidan, F., & Houle, T. T. (2021). Effectiveness of mindfulness meditation vs headache education for adults with migraine: A randomized clinical trial. JAMA Internal Medicine, 181(3), 317–328. https://doi.org/10.1001/jamainternmed.2020.7090CrossRefPubMed

Titel: Intensive Mindfulness Meditation Reduces Frequency and Burden of Migraine: An Unblinded Single-Arm Trial
Auteurs: Madhav Goyal
Jennifer A. Haythornthwaite
Sharat Jain
Barbara Lee Peterlin
Megha Mehrotra
David Levine
Jason D. Rosenberg
Mary Minges
David A. Seminowicz
Daniel E. Ford
Publicatiedatum: 24-01-2023
Uitgeverij: Springer US
Gepubliceerd in: Mindfulness / Uitgave 2/2023
Print ISSN: 1868-8527
Elektronisch ISSN: 1868-8535
DOI: https://doi.org/10.1007/s12671-023-02073-z

Andere artikelen Uitgave 2/2023

Where Have We Been and Where Are We Going with Mindfulness in Schools?

Open Access
COMMENTARY

Beyond All Splits: Envisioning the Next Generation of Science on Mindfulness and Compassion in Schools for Students

Open Access
ORIGINAL PAPER

Brief Mindfulness Instruction Predicts Anonymous Prosocial Helping of an Ostracized Racial Outgroup Member

Original Paper

The Interpersonal Mindfulness in Parenting Scale: Examining the Reliability and Validity in Spanish Parents

Open Access
Original Paper

Exploring the Cross-cultural Applicability of a Brief Compassionate Mind Training: a Study Comparing Sri Lankan and UK People

Open Access
ORIGINAL PAPER

Understanding the Experiences of How Mindfulness is Used by People with Cystic Fibrosis: Barriers and Enablers

Open Access
Original Paper